1,3-Oxazines As Bace1 And/Or Bace2 Inhibitors
    2.
    发明申请
    1,3-Oxazines As Bace1 And/Or Bace2 Inhibitors 审中-公开
    1,3-二恶烷作为Bace1和/或Bace2抑制剂

    公开(公告)号:US20150322054A1

    公开(公告)日:2015-11-12

    申请号:US14803746

    申请日:2015-07-20

    摘要: The present invention provides 4-(3-Amino-phenyl)-5,6-dihydro-4H-[1,3]oxazin-2-ylamines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.

    摘要翻译: 本发明提供具有BACE1和/或BACE2抑制活性的式I的4-(3-氨基 - 苯基)-5,6-二氢-4H- [1,3]恶嗪-2-基胺,其制备方法,含有 它们及其作为治疗活性物质的用途。 本发明的活性化合物可用于例如治疗和/或预防性治疗。 阿尔茨海默病和2型糖尿病。

    1,3-oxazines as BACE1 and/or BACE2 inhibitors
    3.
    发明授权
    1,3-oxazines as BACE1 and/or BACE2 inhibitors 有权
    作为BACE1和/或BACE2抑制剂的1,3-恶嗪

    公开(公告)号:US09115098B2

    公开(公告)日:2015-08-25

    申请号:US14268085

    申请日:2014-05-02

    摘要: The present invention provides 4-(3-Amino-phenyl)-5,6-dihydro-4H-[1,3]oxazin-2-ylamines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.

    摘要翻译: 本发明提供具有BACE1和/或BACE2抑制活性的式I的4-(3-氨基 - 苯基)-5,6-二氢-4H- [1,3]恶嗪-2-基胺,其制备方法,含有 它们及其作为治疗活性物质的用途。 本发明的活性化合物可用于例如治疗和/或预防性治疗。 阿尔茨海默病和2型糖尿病。